08.03.2011 - The U.S. Supreme Court let stand a ruling that drug companies can pay rivals to delay production of generic drugs without violating federal antitrust laws. The justices refused to...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)